AADC Neurons

Aromatic L-Amino Acid Decarboxylase Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">AADC Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Neuromodulatory</td>
</tr>
<tr>
<td class="label">Location</td>
<td>CNS, peripheral</td>
</tr>
<tr>
<td class="label">Enzyme</td>
<td>Aromatic L-amino acid decarboxylase</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Catecholamine synthesis</td>
</tr>
<tr>
<td class="label">Gene/Protein</td>
<td>Function</td>
</tr>
<tr>
<td class="label">AADC (DDC)</td>
<td>Dopamine synthesis enzyme</td>
</tr>
<tr>
<td class="label">[TH](/genes/th)</td>
<td>Rate-limiting step</td>
</tr>
<tr>
<td class="label">[VMAT2](/proteins/vmat2-protein)</td>
<td>Neurotransmitter packaging</td>
</tr>
<tr>
<td class="label">[DAT](/proteins/dat-protein)</td>
<td>Dopamine reuptake</td>
</tr>
<tr>
<td class="label">[COMT](/proteins/comt-protein)</td>
<td>Dopamine metabolism</td>
</tr>
<tr>
<td class="label">[BDNF](/proteins/bdnf-protein)</td>
<td>Neuronal survival</td>
</tr>
<tr>
<td class="label">[LRRK2](/genes/lrrk2)</td>
<td>Kinase dysfunction</td>
</tr>
</table>

Introduction

Aadc Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

...

Aromatic L-Amino Acid Decarboxylase Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">AADC Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Neuromodulatory</td>
</tr>
<tr>
<td class="label">Location</td>
<td>CNS, peripheral</td>
</tr>
<tr>
<td class="label">Enzyme</td>
<td>Aromatic L-amino acid decarboxylase</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Catecholamine synthesis</td>
</tr>
<tr>
<td class="label">Gene/Protein</td>
<td>Function</td>
</tr>
<tr>
<td class="label">AADC (DDC)</td>
<td>Dopamine synthesis enzyme</td>
</tr>
<tr>
<td class="label">[TH](/genes/th)</td>
<td>Rate-limiting step</td>
</tr>
<tr>
<td class="label">[VMAT2](/proteins/vmat2-protein)</td>
<td>Neurotransmitter packaging</td>
</tr>
<tr>
<td class="label">[DAT](/proteins/dat-protein)</td>
<td>Dopamine reuptake</td>
</tr>
<tr>
<td class="label">[COMT](/proteins/comt-protein)</td>
<td>Dopamine metabolism</td>
</tr>
<tr>
<td class="label">[BDNF](/proteins/bdnf-protein)</td>
<td>Neuronal survival</td>
</tr>
<tr>
<td class="label">[LRRK2](/genes/lrrk2)</td>
<td>Kinase dysfunction</td>
</tr>
</table>

Introduction

Aadc Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

AADC is the enzyme that converts L-DOPA to dopamine. [@kuhl2020]

Overview

AADC Function

• DOPA decarboxylation: Final step to dopamine
• 5-HTP decarboxylation: Serotonin synthesis
• Vitamin B6 dependent: Cofactor requirement
• AADC deficiency: Genetic neurotransmitter disorder

Role in Neurodegeneration

[Parkinson's Disease](/diseases/parkinsons-disease)

• AADC activity: Marker of remaining [dopaminergic neurons](/cell-types/dopaminergic-neurons)
• Fluctuations: AADC capacity limits [levodopa](/therapeutics/levodopa) response
• Gene therapy: AADC delivery via [AAV vectors](/technologies/aav-vectors)
• [Fluorodopa PET](/diagnostics/fluorodopa-pet): Imaging marker for [substantia nigra](/cell-types/substantia-nigra) integrity

AADC Gene Therapy

• AAV vectors: Putamen injection
• Clinical trials: Gene therapy
• ComBINE trial: AADC optimization

Molecular Mechanisms

AADC neurons operate through several key molecular mechanisms:

Catecholamine Synthesis

• [Dopamine biosynthesis](/mechanisms/dopamine-biosynthesis): AADC catalyzes the decarboxylation of L-DOPA to dopamine
• [Serotonin synthesis](/mechanisms/serotonin-pathway): AADC also converts 5-HTP to serotonin
• Vitamin B6 dependence: Pyridoxal phosphate is an essential cofactor

Neurotransmitter Regulation

• Tyrosine hydroxylase: Rate-limiting step before AADC
• VMAT2: Vesicular packaging of synthesized neurotransmitters
• DAT: Dopamine reuptake regulation

Disease-Related Pathways

• Basal ganglia circuitry: AADC activity in PD
• Neuroinflammation: Effects on AADC function
• Oxidative stress: Impact on enzyme activity

Key Genes and Proteins

Signaling Pathways

• cAMP/PKA signaling: Dopamine receptor signaling
• PI3K/Akt pathway: Cell survival signaling
• MAPK/ERK pathway): Growth factor signaling
• Calcium signaling: Excitotoxicity mechanisms

Therapeutic Implications

Disease-Modifying Approaches

• AADC gene therapy: [AAV-mediated](/technologies/aav-vectors) AADC delivery to [striatum](/cell-types/striatal-medium-spiny-neurons)
• Cell replacement: [AADC-expressing stem cell transplants](/cell-types/ipsc-derived-dopaminergic-neurons)
• Enzyme enhancement: Small molecule AADC activators

Neuroprotective Strategies

• [GDNF](/proteins/gdnf-protein): Neuronal survival factors
• [BDNF analogs](/proteins/bdnf-protein): Support AADC neuron function
• Antioxidants: Protect AADC activity from [oxidative stress](/mechanisms/oxidative-stress)

Symptomatic Treatments

• [Levodopa](/therapeutics/levodopa): AADC substrate for dopamine synthesis
• [MAO-B inhibitors](/therapeutics/mao-b-inhibitors): Prevent dopamine breakdown
• [Dopamine agonists](/therapeutics/dopamine-agonists): Bypass AADC limitation

Emerging Therapies

• Optogenetics: Light-based modulation of AADC neurons
• Chemogenetics: Designer receptors for neuronal control
• Gene editing: CRISPR-based AADC enhancement

Disease Associations

• [Parkinson's disease](/diseases/parkinsons-disease): Primary AADC neuron disorder
• [Multiple system atrophy](/diseases/multiple-system-atrophy): Atypical parkinsonism affecting AADC
• [Progressive supranuclear palsy](/diseases/progressive-supranuclear-palsy): Tauopathy with parkinsonian features
• [AADC deficiency](/diseases/aadc-deficiency): Genetic neurotransmitter disorder
• [Dopa-responsive dystonia](/diseases/dopa-responsive-dystonia): AADC-related movement disorder

Background

The study of Aadc Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

• [Parkinson's disease](/diseases/parkinsons-disease) alpha-synuclein
• genetic factors
• APOE4
• biomarkers

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data